Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.10), $0.02 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $4.93 million versus the consensus estimate of $4.82 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.